Psyllium Husk vs Semaglutide for appetite
Short answer: For appetite, more users report improvement with Psyllium Husk — 100% of 8 reports, versus 83% of 64 for Semaglutide.
Psyllium Husk has 49 meta-analyses and 145 randomized trials on PubMed; Semaglutide has 421 and 307.
Based on 114 reports about Psyllium Husk and 314 about Semaglutide. Not medical advice.
| Psyllium Husk Supplement | Semaglutide Medication | |
|---|---|---|
| User score | 70 | 64 |
| Verdict | Mostly positive | Mostly positive |
| Positive of reports that state an outcome | 79% | 64% |
| Reports | 114 | 314 |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 49 / 145 | 421 / 307 |
| Mainly used for | ||
| Weight loss % reporting improvement | 100% (3) | 84% (129) |
| Appetite % reporting improvement | 100% (8) | 83% (64) |
| Focus % reporting improvement | 100% (2) | 60% (5) |
| Energy % reporting improvement | 100% (3) | 39% (23) |
| Sleep % reporting improvement | 100% (3) | 50% (4) |
| Mood % reporting improvement | — | 27% (11) |
| Performance % reporting improvement | — | 83% (6) |
| Recovery % reporting improvement | — | 100% (2) |
| Pain & inflammation % reporting improvement | — | 80% (5) |
| Digestion % reporting improvement | 88% (68) | 43% (7) |
| Libido % reporting improvement | — | 0% (3) |
| Hormones % reporting improvement | — | 100% (2) |
| Blood sugar % reporting improvement | — | 88% (8) |
| Heart & lipids % reporting improvement | 100% (13) | 100% (3) |
| Skin & hair % reporting improvement | — | 33% (3) |
| Common side effects | stomach issues, dizziness, gagging/nausea from, blockage risk | nausea, fatigue, stomach issues, constipation |
| Typical dose reported | rotated | 2.4 mg / once weekly |
Several foods distinctly modify LDL cholesterol levels. The results may aid future guidelines and dietary advice for hypercholesterolemia.
Nutr Metab Cardiovasc Dis, 2021 ↗“It helped me heal my intestinal issues. I felt amazing after about a week and my mental clarity and energy skyrocketed.”
This study shows that new anti-diabetic drugs, particularly GLP1-RA and Tirzepatide, are the most effective in inducing weight loss in patients with type 2 diabetes. Interestingly, exenatide appears to be the only GLP1-RA that induces a mild weight loss.
Pharmacol Res, 2021 ↗“I've lost 35lbs since then and now I'm in the Healthy range on BMI. My IBSD has virtually disappeared.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate